BVS Q3 2023 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$121M-6.1% YoY

Gross Profit

$79M65.3% margin

Operating Income

$2M2.0% margin

Net Income

-$7M-6.0% margin

EPS (Diluted)

$-0.12

QoQ Revenue Growth

-11.9%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$811M

Total Liabilities

$585M

Stockholders' Equity

$178M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121M	$129M	-6.1%
Gross Profit	$79M	$85M	-6.7%
Operating Income	$2M	-$127M	+101.9%
Net Income	-$7M	-$108M	+93.3%

Geographic Segments

UNITED STATES

$106M88%

Non-US

$15M12%